Tin tức & Cập nhật
Xem bài viết Đa khoa
Xem
Chemoimmunotherapeutic agents boost lymphocytic leukaemia survival
The introduction and use of chemoimmunotherapeutic agents such as rituximab, ofatumumab, and obinutuzumab has led to population-level improvements in survival from chronic lymphocytic leukaemia (CLL), a recent study has found.
Chemoimmunotherapeutic agents boost lymphocytic leukaemia survival
14 Nov 2021
Greater pain intensity, more pain sites predict nonrecovery from recent-onset low back pain
About a third of patients who present to an emergency department with recent-onset low back pain fail to recover within 12 months, with factors such as higher pain levels and more pain sites, among others, being prognostic of complete nonrecovery within 6 months, according to a study.
Greater pain intensity, more pain sites predict nonrecovery from recent-onset low back pain
13 Nov 2021
Noncardiac surgeries up MI risk post-implantation of DES in ACS, SAP patients
In acute coronary syndrome (ACS) and stable angina pectoris (SAP) patients, undergoing surgery within a year after implantation of drug-eluting stent (DES) increases the risk of myocardial infarction (MI) and death, a recent study has found.
